Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autore principale: Lückel, Christina
Altri autori: Huber, Magdalena (Prof. Dr.) (Relatore della tesi)
Natura: Dissertation
Lingua:inglese
Pubblicazione: Philipps-Universität Marburg 2018
Soggetti:
multiple sclerosis
IL-17
Multiple Sklerose
ROS
Tc17 cells
Dimethyl fumarate
Tc17 Zellen
Dimethylfumarat
Medizin
Medical sciences Medicine
Accesso online:PDF Full Text
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

PDF Full Text

Dettagli sul posseduto da
Collocazione: urn:nbn:de:hebis:04-z2018-03301
Data di pubblicazione: 2019-02-28
Datum der Annahme: 2018-08-15
Downloads: 45 (2024), 86 (2023), 69 (2022), 72 (2021), 76 (2020), 69 (2019)
Lizenz: https://creativecommons.org/licenses/by-nc-sa/4.0
URL di accesso: https://archiv.ub.uni-marburg.de/diss/z2018/0330
https://doi.org/10.17192/z2018.0330

Documenti analoghi